| Synonyms: | |
| Status: | Approved (1959) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | A08AA01 |
| UNII: | C045TQL4WP |
| InChI Key | DHHVAGZRUROJKS-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C10H15N |
| Molecular Weight | 149.24 |
| AlogP | 1.97 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 26.02 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 11.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | 0 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Trace amine receptor
|
5470 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus | 2 | D003920 | ClinicalTrials |
| Obesity, Morbid | 2 | D009767 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Substance-Related Disorders | 1 | D019966 | ClinicalTrials |
| Bulimia Nervosa | 1 | D052018 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 122-09-8 |
| ChEBI | 8080 |
| ChEMBL | CHEMBL1574 |
| DrugBank | DB00191 |
| DrugCentral | 2140 |
| EPA CompTox | DTXSID9023461 |
| FDA SRS | C045TQL4WP |
| Human Metabolome Database | HMDB0014337 |
| Guide to Pharmacology | 7269 |
| KEGG | C07438 |
| PharmGKB | PA164748099 |
| PubChem | 4771 |
| SureChEMBL | SCHEMBL26615 |
| ZINC | ZINC000008403947 |